# Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera

> **NCT01895855** · PHASE3 · COMPLETED · sponsor: **Bavarian Nordic** · enrollment: 197 (actual)

## Conditions studied

- Cholera

## Interventions

- **BIOLOGICAL:** PXVX0200
- **BIOLOGICAL:** placebo

## Key facts

- **NCT ID:** NCT01895855
- **Lead sponsor:** Bavarian Nordic
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 197 (ACTUAL)
- **Last updated:** 2023-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01895855

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01895855, "Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01895855. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*